Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

HongLiang Li

Showing results (51-60 of 900) with videos related to

Pageof 90
Sort By:
Frontiers in Genetics|September 6, 2023
Identification and verification of novel immune-related ferroptosis signature with excellent prognostic predictive and clinical guidance value in hepatocellular carcinomaWenxiu Jiang, Lili Wang, Yajuan Zhang, et al.
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue|December 6, 2014
[Investigation of adjuvant treatment for difficult weaning from mechanical ventilation]Lijing Jia, Hongliang Li, Yu Bai, et al.
Hepatology (Baltimore, Md.)|December 29, 2015
Liver capsule: IRFs in hepatocytes: PathophysiologyPi-Xiao Wang, Xiao-Jing Zhang, Hongliang Li
Journal of Ethnopharmacology|October 4, 2020
Involvement of mTOR/Survivin signaling pathway in TUA(2β, 3β, 23-trihydroxy-urs-12-ene-28-olic acid)-induced apoptosis in human gastric cancer cell line BGC823 cellsQilai Cheng, Yingchen Li, Xiaohua Guo, et al.
GE Portuguese Journal of Gastroenterology|October 9, 2025
Giant Hepatic Hemangioma: Diagnostic ChallengesYing Zhao, Ruohan Zhu, Hongliang Li, et al.
Cancer Management and Research|November 11, 2020
Circ-ATP5H Induces Hepatitis B Virus Replication and Expression by Regulating miR-138-5p/<i>TNFAIP3</i> AxisWenxiu Jiang, Lili Wang, Yajuan Zhang, et al.
Annual Review of Pathology|September 20, 2018
Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular DiseasesJingjing Cai, Meng Xu, Xiaojing Zhang, et al.
British Journal of Pharmacology|August 19, 2014
The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseasesXiao-Jing Zhang, Ding-Sheng Jiang, Hongliang Li
Frontiers in Cellular and Infection Microbiology|March 16, 2026
Point-of-care molecular diagnostics and drug-resistance mechanisms in neglected infectious diseases: current advances and future therapeutic opportunitiesQi Zhang, Xiajun Zhang, Jie Yang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 5, 2019
Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver DiseasesYao Yu, Jingjing Cai, Zhigang She, et al.
Pageof 90

Showing results (51-60 of 900) with videos related to

Sort By:
Pageof 90
Frontiers in Genetics|September 6, 2023
Identification and verification of novel immune-related ferroptosis signature with excellent prognostic predictive and clinical guidance value in hepatocellular carcinomaWenxiu Jiang, Lili Wang, Yajuan Zhang, et al.
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue|December 6, 2014
[Investigation of adjuvant treatment for difficult weaning from mechanical ventilation]Lijing Jia, Hongliang Li, Yu Bai, et al.
Hepatology (Baltimore, Md.)|December 29, 2015
Liver capsule: IRFs in hepatocytes: PathophysiologyPi-Xiao Wang, Xiao-Jing Zhang, Hongliang Li
Journal of Ethnopharmacology|October 4, 2020
Involvement of mTOR/Survivin signaling pathway in TUA(2β, 3β, 23-trihydroxy-urs-12-ene-28-olic acid)-induced apoptosis in human gastric cancer cell line BGC823 cellsQilai Cheng, Yingchen Li, Xiaohua Guo, et al.
GE Portuguese Journal of Gastroenterology|October 9, 2025
Giant Hepatic Hemangioma: Diagnostic ChallengesYing Zhao, Ruohan Zhu, Hongliang Li, et al.
Cancer Management and Research|November 11, 2020
Circ-ATP5H Induces Hepatitis B Virus Replication and Expression by Regulating miR-138-5p/<i>TNFAIP3</i> AxisWenxiu Jiang, Lili Wang, Yajuan Zhang, et al.
Annual Review of Pathology|September 20, 2018
Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular DiseasesJingjing Cai, Meng Xu, Xiaojing Zhang, et al.
British Journal of Pharmacology|August 19, 2014
The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseasesXiao-Jing Zhang, Ding-Sheng Jiang, Hongliang Li
Frontiers in Cellular and Infection Microbiology|March 16, 2026
Point-of-care molecular diagnostics and drug-resistance mechanisms in neglected infectious diseases: current advances and future therapeutic opportunitiesQi Zhang, Xiajun Zhang, Jie Yang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 5, 2019
Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver DiseasesYao Yu, Jingjing Cai, Zhigang She, et al.
Pageof 90